Tozadenant: Completed Phase IIb enrollment

Biotie completed enrollment of 420 patients treated with levodopa in a double-blind, placebo-controlled, international Phase IIb trial to evaluate 60, 120, 180 and 240 mg oral tozadenant twice daily. ...